GLP-1s for Obstructive Sleep Apnea Obstructive sleep apnea is a disorder in which people briefly stop breathing or breathe very shallowly during sleep, multiple times per hour
While medications such as Ozempic, Wegovy, Mounjaro, and Rybelsus reduce appetite and regulate metabolism, long-term success is strongest when combined with lifestyle changes
Once beneficiaries reach their out-of-pocket maximum (set at $2,400 in 2027), they will pay $0 for their medications, including for model drugs
Like all medications, however, it comes with potential side effects
protect from light Single-dose devices (used once and discarded) have no "after first use" storage period because they should be discarded immediately after injection: Semaglutide (Wegovy) : Single-dose pen
Other recognized adverse effects include injection site reactions, fatigue, headache, and dizziness